Home › Core › ISCC-IDs › 28C6pmxvioDMT

View ISCC-ID

Core Data

28C6pmxvioDMT
ISCC-ID - digital asset identifier
CCab4STbxyWke-CTAh1wwRD1DE4-CDHVM1EPoZoyN-CRHWvPzU1DyF8
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

troglitazone amplifies counterregulatory responses to hypoglycemia in nondiabetic subjects1

Ledger Reference

coblo
Source Ledger/Blockchain
12407811
N-th ISCC Decleration on source ledger
724de37fe099681660b8091660d6ea87c9f247ade2676ed4bf62e9f4ed1d1d3c
Hash of block that includes the ISCC-DECLARATION
28d97d214fff1a0fc5b3b040f91cbb9922a11195a19b9cadedeeaa8b69c05178
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Troglitazone Amplifies Counterregulatory Responses to Hypoglycemia in Nondiabetic Subjects1", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Ilan Gabriely", "@type": "Person"}, {"name": "Robert Wozniak", "@type": "Person"}, {"name": "Meredith Hawkins", "@type": "Person"}, {"name": "Harry Shamoon", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://academic.oup.com/jcem/article-pdf/86/2/521/9129912/jcem0521.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "The Endocrine Society", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1210/jcem.86.2.7197", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCab4STbxyWke-CTAh1wwRD1DE4-CDHVM1EPoZoyN-CRHWvPzU1DyF8", "propertyID": "ISCC"}], "datePublished": "2001-02-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close